The full text of this article hosted at iucr.org is unavailable due to technical difficulties.

The good and the bad: what researchers have learned about dietary cholesterol, lipid management and cardiovascular disease risk since the Harvard Egg Study

C. Constance

Division of Cardiology, University of Montreal, QC, Canada

Search for more papers by this author
First published: 14 September 2009
Cited by: 4
C. Constance,
Division of Cardiology, University of Montreal, QC, Canada
Tel.: 514 2523813
Fax: 514 2523835
Email: constancec@videotron.ca

Disclosure
None.

Summary

Background: The prevalence of cardiovascular diseases, while lower than it once was, remains a significant health consideration.

Aims and Methods: To review the evolving evidence with respect to what role various factors play in the aetiology of coronary heart disease (CHD).

Results: While total cholesterol and low‐density lipoprotein cholesterol (LDL‐C) were previously believed to play central roles, it has now become clear that neither in isolation is highly significant. For example, some people with very high LDL‐C levels do not develop CHD, while others with very low LDL‐C levels do. Furthermore, there is a difference between dietary cholesterol and serum cholesterol. Dietary cholesterol, which is found in animal‐based foods, raises blood cholesterol in only approximately one‐third of people. Conversely, intake of saturated fatty acids and trans fatty acids can result in dyslipidaemia. Furthermore, obesity ‐ particularly abdominal obesity ‐ and metabolic syndrome both are strong independent risk factors for development of cardiovascular disease.

Conclusions: Statin therapy and a diet comprising a portfolio of plant sterols and viscous fibres can both significantly reduce LDL‐C levels and C‐reactive protein. The latter is a key marker of inflammation and of elevated risk for cardiovascular disease.

Number of times cited: 4

  • , Handbook of eggs in human function, (153)
  • , A high‐fibre bean‐rich diet versus a low‐carbohydrate diet for obesity, Journal of Human Nutrition and Dietetics, 27, (109-116), (2013).
  • , Strategic planning for the development of the egg nutraceutical industry, Improving the Safety and Quality of Eggs and Egg Products, 10.1533/9780857093929.3.374, (374-399), (2011).
  • , Revisiting Dietary Cholesterol Recommendations: Does the Evidence Support a Limit of 300 mg/d?, Current Atherosclerosis Reports, 12, 6, (377), (2010).